E-ISSN 0976-2779 | ISSN 0975-8453
 

Review Article 


Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer

Zainab Nizar Jawad, Kamal A.R, Weaam awad.

Abstract
Tumor of urinary bladder nowadays is regarded as one of the most prevalent human cancer allover our planet. Many predisposing factors play a crucial role in the pathogenesis of this tumor including endogenous and exogenous blamed causes. Certain polymorphism of CYP1A1 gene recently has been linked to the occurrence of bladder cancer. Pioglitazone that used for treatment of diabetes mellitus type II for long time carry a risk impact on induction of this tumor.
Aim of this study: To evaluate the risk of using of pioglitazone in patients who carry CYP1A1 polymorphism to induce bladder carcinoma.
Materials and method: This study was conducted from 2017 to 2019, 80 patients with bladder cancer after being medically diagnosed and were assessed if using of pioglitazone with presence of CYP1A1 polymorphisms associated with high risk of CA bladder. DNA was extracted and molecular detection was performed to detect single nucleotide polymorphisms (SNPs) at genetic sites using PCR and PCR-RFLP techniques.
Results: There was additive risk by using of pioglitazone for long time (at least 1 year) in occurrence of CA bladder in individuals with CYP1A1 polymorphisms.

Key words: CA bladder, pioglitazone. CYP1A1 polymorphisms


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Zainab Nizar Jawad
Articles by Kamal A.R
Articles by Weaam awad
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad. Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer. SRP. 2020; 11(5): 375-376. doi:10.31838/srp.2020.5.53


Web Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad. Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer. http://www.sysrevpharm.org//?mno=109235 [Access: May 25, 2020]. doi:10.31838/srp.2020.5.53


AMA (American Medical Association) Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad. Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer. SRP. 2020; 11(5): 375-376. doi:10.31838/srp.2020.5.53



Vancouver/ICMJE Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad. Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer. SRP. (2020), [cited May 25, 2020]; 11(5): 375-376. doi:10.31838/srp.2020.5.53



Harvard Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad (2020) Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer. SRP, 11 (5), 375-376. doi:10.31838/srp.2020.5.53



Turabian Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad. 2020. Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer. Systematic Reviews in Pharmacy, 11 (5), 375-376. doi:10.31838/srp.2020.5.53



Chicago Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad. "Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer." Systematic Reviews in Pharmacy 11 (2020), 375-376. doi:10.31838/srp.2020.5.53



MLA (The Modern Language Association) Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad. "Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer." Systematic Reviews in Pharmacy 11.5 (2020), 375-376. Print. doi:10.31838/srp.2020.5.53



APA (American Psychological Association) Style

Zainab Nizar Jawad, Kamal A.R, Weaam awad (2020) Association of Additive Risk of Pioglitazone Use with the Presence of CYP1A1 Polymorphisms in the Occurrence of Bladder Cancer. Systematic Reviews in Pharmacy, 11 (5), 375-376. doi:10.31838/srp.2020.5.53





Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study
    Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli
    SRP. 2020; 11(1): 01-06
    » Abstract » doi: 10.5530/srp.2020.1.01

  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context
    Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran
    SRP. 2020; 11(1): 14-22
    » Abstract » doi: 10.5530/srp.2020.1.03

  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata
    Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi
    SRP. 2019; 10(1): 15-19
    » Abstract » doi: 10.5530/srp.2019.1.3

  • A Review of Pharmacoeconomics: the key to “Healthcare for All”
    Hasamnis AA, Patil SS, Shaik Imam, Narendiran K
    SRP. 2019; 10(1): s40-s42
    » Abstract » doi: 10.5530/srp.2019.1s.21

  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer
    Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova
    SRP. 2019; 10(1): 112-117
    » Abstract » doi: 10.5530/srp.2019.1.19

  • Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study
    Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli
    SRP. 2020; 11(1): 01-06
    » Abstract » doi: 10.5530/srp.2020.1.01

  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review
    Karle Pravin P, Dhawale Shashikant C
    SRP. 2019; 10(1): 11-14
    » Abstract » doi: 0.5530/srp.2019.1.2

  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba
    Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar
    SRP. 2019; 10(1): 20-25
    » Abstract » doi: 10.5530/srp.2019.1.4

  • A Review of Pharmacoeconomics: the key to “Healthcare for All”
    Hasamnis AA, Patil SS, Shaik Imam, Narendiran K
    SRP. 2019; 10(1): s40-s42
    » Abstract » doi: 10.5530/srp.2019.1s.21

  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata
    Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi
    SRP. 2019; 10(1): 15-19
    » Abstract » doi: 10.5530/srp.2019.1.3

  • Most Cited Articles